MAIA Biotechnology Statistics Share Statistics MAIA Biotechnology has 32.99M
shares outstanding. The number of shares has increased by 26.77%
in one year.
Shares Outstanding 32.99M Shares Change (YoY) 26.77% Shares Change (QoQ) 15.86% Owned by Institutions (%) 5.33% Shares Floating 23.88M Failed to Deliver (FTD) Shares 2,653 FTD / Avg. Volume 0.63%
Short Selling Information The latest short interest is 626.63K, so 1.9% of the outstanding
shares have been sold short.
Short Interest 626.63K Short % of Shares Out 1.9% Short % of Float 2.2% Short Ratio (days to cover) 2.28
Valuation Ratios The PE ratio is -1.89 and the forward
PE ratio is -2.16.
MAIA Biotechnology's PEG ratio is
0.06.
PE Ratio -1.89 Forward PE -2.16 PS Ratio 0 Forward PS 0.8 PB Ratio 12.09 P/FCF Ratio -2.8 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MAIA Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.65,
with a Debt / Equity ratio of 0.
Current Ratio 2.65 Quick Ratio 2.65 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -297491.23
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.79M Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -79.95K Effective Tax Rate 0.34%
Stock Price Statistics The stock price has increased by -51.42% in the
last 52 weeks. The beta is 0.03, so MAIA Biotechnology's
price volatility has been higher than the market average.
Beta 0.03 52-Week Price Change -51.42% 50-Day Moving Average 1.66 200-Day Moving Average 1.82 Relative Strength Index (RSI) 47.28 Average Volume (20 Days) 424,414
Income Statement
Revenue n/a Gross Profit n/a Operating Income -16.96M Net Income -23.25M EBITDA -16.96M EBIT -16.96M Earnings Per Share (EPS) -1.05
Full Income Statement Balance Sheet The company has 9.6M in cash and 0 in
debt, giving a net cash position of 9.6M.
Cash & Cash Equivalents 9.6M Total Debt n/a Net Cash n/a Retained Earnings -87.23M Total Assets 11.05M Working Capital 6M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -15.7M
and capital expenditures 0, giving a free cash flow of -15.7M.
Operating Cash Flow -15.7M Capital Expenditures n/a Free Cash Flow -15.7M FCF Per Share -0.71
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
